Rubinstein-Taybi Syndrome and Epigenetic Alterations

Area of Science:

• Genetics
• Epigenetics
• Developmental Biology

Background:

• Rubinstein-Taybi syndrome (RSTS) is a rare genetic disorder characterized by developmental delays and intellectual disability.
• RSTS is linked to mutations in epigenetics-associated genes, primarily CREBBP (encoding CBP) and EP300 (encoding p300).
• CBP possesses histone acetyltransferase activity crucial for gene expression and has been implicated in higher cognitive functions.

Purpose of the Study:

• To explore the role of CBP in cognitive function within the context of Rubinstein-Taybi syndrome.
• To investigate the epigenetic mechanisms underlying RSTS, focusing on the CBP gene.
• To understand the etiology of RSTS, despite research on CREBBP in rodents.

Main Methods:

• Review of existing literature on RSTS, CBP, and epigenetic mechanisms.
• Analysis of studies on cognitive functions in mouse models involving CBP.
• Examination of the histone acetyltransferase activity of CBP and its role in gene expression.

Main Results:

• Heterozygous mutations in the CBP gene are associated with RSTS and suggest a role for CBP in higher cognitive functions.
• CBP's histone acetyltransferase activity is essential for CREB-mediated gene expression, potentially by destabilizing nucleosomes.
• The complexity of RSTS and potential genetic compensation make it challenging to directly link CBP to adult cognitive function.

Conclusions:

• While CBP's role in gene regulation and cognitive function is supported by genetic evidence in RSTS and mouse models, its direct impact in the adult human brain remains complex.
• The precise etiology of RSTS in humans is not fully understood, necessitating further research despite extensive studies in rodents.
• Prenatal genetic testing for RSTS is rarely considered due to its rarity and the postnatal manifestation of many symptoms.